Title : Subcutaneous Rituximab-MiniCHOP Compared With Subcutaneous Rituximab-MiniCHOP Plus Lenalidomide in Diffuse Large B-Cell Lymphoma for Patients Age 80 Years or Older.

Pub. Date : 2021 Apr 10

PMID : 33444079






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In combination with R-CHOP (R2-CHOP), lenalidomide has an acceptable level of toxicity and may mitigate the negative prognosis of the non-germinal center B-cell-like phenotype. Lenalidomide DNA damage inducible transcript 3 Homo sapiens